ATAI
group average changes in beta power for low dose and high dose groups per time point average differences in each time point is compared to zero and time points with significant changes test were marked with asterisk preliminary data subject to change phase the effect was also time dependent showing a rapid onset of effect a delayed pharmacodynamic curve | ATAI
Company
Deck Type
Sector
Industry
Deck date
March 2023
Slide
25 of 31
Similar slides by ATAI
See diffirences between slides (animation)
Investor Presentation
April 2023
group average changes in beta power for low dose and high dose groups per time point average differences in each time point is compared to zero and time points with significant changes test were marked with asterisk phase data the effect was also time dependent showing a rapid onset of effect a delayed pharmacodynamic curve | ATAI
Investor Presentation
February 2023
group average changes in beta power for low dose and high dose groups per time point average differences in each time point is compared to zero and time points with significant changes test were marked with asterisk preliminary data subject to change phase the effect was also time dependent showing a rapid onset of effect a delayed pharmacodynamic curve | ATAI
Investor Presentation
January 2023
group average changes in beta power for low dose and high dose groups per time point average differences in each time point is compared to zero and time points with significant changes test were marked with asterisk preliminary data subject to change phase the effect was also time dependent showing a rapid onset of effect a delayed pharmacodynamic curve | ATAI
Investor Presentation
October 2022
group average changes in beta power for low dose and high dose groups per time point changes in beta power averaged over each channel from dose to each time point dose power subtracted from post dose at each point average differences in each time point is compared to zero and time points with significant changes test were marked with asterisk preliminary data subject to change pharmacodynamic effect the effect dose dependent time dependent showing a rapid onset of efficacy a delayed curve | ATAI
Related slides by other companies
Nuvectis Pharma
Investor Presentation
August 2023
phase underway fast track designation | Nuvectis Pharma
BioNTech
Results
November 2020
safety trial in patients with malignant solid tumors who are not bot | BioNTech
Ocuphire Pharma
Investor Day
January 2022
phase clinical trials data supporting the zeta trial rat aches high levels in rat eye is orally | Ocuphire Pharma
DoorDash
Mergers and Acquisitions
November 2021
projects divinities presentations investor presentation warsaw investor presentation obsessive focus on logistics average delivery time rolling week average minutes deliveries per hour rolling week average including idle time ability to drive network in low density cities has driven average delivery times down deliveries per hour has steadily increased while reducing average delivery time efficiency | DoorDash
Other recent decks by ATAI
See all presentations (13 decks)
Investor Presentation
January 2024
Investor Presentation
October 2023
Investor Conference
May 2023
Investor Presentation
April 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io